SENSYO Pharmatech is the result of a partnership between BAB banking consortium, composed of Bank of Africa, Banque Centrale Populaire and Attijariwafa bank, Recipharm and the Mohammed VI Fund. It establishes the beginning of a new era of vaccine independence in Morocco and Africa, in order to reinforce the global bio therapeutics production capacity and fulfil increasing and more complex demands.